Urogenital atrophy in the postmenopausal or castrated woman is common with a multifactorial etiology and a varied clinical presentation. The effects of age and estrogen deprivation are, at times, poorly separable. Estrogen replacement may be used to significantly alleviate symptoms due to atrophy but must be used with appropriate surveillance to avoid potential adverse consequences.